Literature DB >> 25361186

Evaluation of the Xpert MTB/RIF assay in gastric lavage aspirates for diagnosis of smear-negative childhood pulmonary tuberculosis.

Yu Pang1, Yufeng Wang, Shunying Zhao, Jinrong Liu, Yanlin Zhao, Huimin Li.   

Abstract

BACKGROUND: The diagnosis of pulmonary tuberculosis (TB) in children presents problems worldwide. The Xpert MTB/RIF assay serves as a useful alternative for the rapid diagnosis of childhood TB, with various clinical specimens.
METHODS: In this study, we evaluated the Xpert for diagnosis of smear-negative childhood pulmonary TB using gastric lavage aspirates (GLA). A total of 211 eligible children with suspected TB were consecutively recruited and had GLA obtained for analysis between October 2012 and October 2013 in Beijing Children's Hospital.
RESULTS: The percentages of TB children in <1 year [Odds ratio (95% confidence interval): 4.66 (1.81-11.97)], >5 years group [2.59 (1.30-5.16)] and of living in a rural region [3.78 (2.02-7.08)] were significantly higher than in control groups. The sensitivity in detecting children with a clinical diagnosis of TB for MGIT and Xpert was 12.1% (95% confidence interval: 9.3-14.9%) and 48.6% (95% confidence interval: 44.4-52.8%), respectively. The statistical analysis revealed that GeneXpert showed significantly better sensitivity than MGIT technology (P < 0.001).
CONCLUSIONS: We conclude that Xpert MTB/RIF assay is an excellent tool for the diagnosis of smear-negative childhood with GLA samples. The high proportion of very low mycobacterial load in the GLA samples from smear-negative TB cases may increase the frequency for obtaining indeterminate RIF resistance results by Xpert. In addition, the age <1 year, >5 years and living in a rural region are all high risk factors for childhood TB cases in China.

Entities:  

Mesh:

Year:  2014        PMID: 25361186     DOI: 10.1097/INF.0000000000000403

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  16 in total

Review 1.  Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children: a systematic review and meta-analysis.

Authors:  Anne K Detjen; Andrew R DiNardo; Jacinta Leyden; Karen R Steingart; Dick Menzies; Ian Schiller; Nandini Dendukuri; Anna M Mandalakas
Journal:  Lancet Respir Med       Date:  2015-03-24       Impact factor: 30.700

2.  Piloting Upfront Xpert MTB/RIF Testing on Various Specimens under Programmatic Conditions for Diagnosis of TB & DR-TB in Paediatric Population.

Authors:  Neeraj Raizada; Kuldeep Singh Sachdeva; Soumya Swaminathan; Shubhangi Kulsange; Sunil D Khaparde; Sreenivas Achuthan Nair; Ashwani Khanna; Kamal Kishore Chopra; Mahmud Hanif; Gulshan Rai Sethi; K R Umadevi; G Keshav Chander; Brojakishore Saha; Amar Shah; Malik Parmar; Mayank Ghediya; Jyoti Jaju; Catharina Boehme; Chinnambedu Nainarappan Paramasivan
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

3.  Diagnostic dilemma of pulmonary tuberculosis among adults with severe mental illness in Beijing, China.

Authors:  Li Wang; Zhiguo Zhang; Qiuli Yan; Jie Lu; Baoyin Gao; Yanlin Zhao; Yu Pang
Journal:  BMC Infect Dis       Date:  2017-01-18       Impact factor: 3.090

4.  Factors Associated with Missed Detection of Mycobacterium tuberculosis by Automated BACTEC MGIT 960 System.

Authors:  Yu Pang; Biyi Su; Huiwen Zheng; Zhiguo Zhang; Aijing Ma; Yufeng Wang; Yanlin Zhao
Journal:  Biomed Res Int       Date:  2016-12-19       Impact factor: 3.411

5.  The Feasibility of Xpert MTB/RIF Testing to Detect Rifampicin Resistance among Childhood Tuberculosis for Prevalence Surveys in Northern China.

Authors:  Jie Lu; Huimin Li; Fang Dong; Jin Shi; Hui Yang; Shujing Han; Ping Chu; Yanlin Zhao; Wenqi Song; Yongli Guo; Shunying Zhao
Journal:  Biomed Res Int       Date:  2017-12-05       Impact factor: 3.411

6.  Rifabutin Resistance Associated with Double Mutations in rpoB Gene in Mycobacterium tuberculosis Isolates.

Authors:  Wei Jing; Yu Pang; Zhaojing Zong; Jing Wang; Ru Guo; Fengmin Huo; Guanglu Jiang; Yifeng Ma; Hairong Huang; Naihui Chu
Journal:  Front Microbiol       Date:  2017-09-14       Impact factor: 5.640

7.  GeneXpert MTB/RIF assay in the diagnosis of urinary tuberculosis from urine specimens.

Authors:  Yu Pang; Yuanyuan Shang; Jie Lu; Qian Liang; Lingling Dong; Yunxu Li; Liping Zhao; Guanglu Jiang; Hairong Huang
Journal:  Sci Rep       Date:  2017-07-21       Impact factor: 4.379

8.  GeneXpert MTB/RIF Outperforms Mycobacterial Culture in Detecting Mycobacterium tuberculosis from Salivary Sputum.

Authors:  Jin Shi; Wenzhu Dong; Yifeng Ma; Qian Liang; Yuanyuan Shang; Fen Wang; Hairong Huang; Yu Pang
Journal:  Biomed Res Int       Date:  2018-04-01       Impact factor: 3.411

9.  A Comprehensive Evaluation of Xpert MTB/RIF Assay With Bronchoalveolar Lavage Fluid as a Single Test or Combined With Conventional Assays for Diagnosis of Pulmonary Tuberculosis in China: A Two-Center Prospective Study.

Authors:  Xiaofu Pan; Shoufeng Yang; Margaret A Deighton; Yue Qu; Liang Hong; Feifei Su
Journal:  Front Microbiol       Date:  2018-03-13       Impact factor: 5.640

10.  Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.

Authors:  Alexander W Kay; Lucia González Fernández; Yemisi Takwoingi; Michael Eisenhut; Anne K Detjen; Karen R Steingart; Anna M Mandalakas
Journal:  Cochrane Database Syst Rev       Date:  2020-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.